Latest Export Market Expansion News

Page 1 of 1

EVE Health Clears Regulatory Path for Australian Launch of Libbo and Dyspro

EVE Health Group has secured regulatory approval enabling prescription access for its lead products Libbo and Dyspro in Australia, setting the stage for a commercial rollout before the end of 2025.

Ada Torres

21 July 2025

Top